Breaking News Instant updates and real-time market news.

POAI

Predictive Oncology

$1.74 /

+0.03 (+1.75%)

08:34
06/18/20
06/18
08:34
06/18/20
08:34

Predictive Oncology's TumorGenesis division secures commercial sale

Predictive Oncology announces that Predictive's TumorGenesis division sold its first order of its unique ovarian cancer cell culture media for cancer cells collected from patient derived samples through its distributor US Biological Corporation. The media used to grow the novel and unique ovarian cancer cell lines, licensed by TumorGenesis and its partner, GLG Pharma are able to retain 95%+ of the DNA and RNA as well as crucial proteomic signatures. The media was sold to a top rated medical university in the New England area for research in isolating and growing ovarian cancer cells from the fluid often found in the abdomen of women with advanced ovarian cancer, called the 'ascites' fluid. Ovarian cancer cell culturing from ascites fluids are notoriously difficult using standard media mixes often prone to failure and cell lines that are not representative of the patient's ovarian cancer.

TODAY'S FREE FLY STORIES

Upgrade
Hansa Biopharma upgraded to Outperform from Sector Perform at RBC Capital » 05:40
07/07/20
07/07
05:40
07/07/20
05:40
HNSBF

Hansa Biopharma

$0.00 /

+ (+0.00%)

RBC Capital analyst Zoe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNSBF Hansa Biopharma
$0.00 /

+ (+0.00%)

07/02/20 William Blair
Sarepta's recent deals may expand eligible patient set, says William Blair
Upgrade
Trex Company upgraded to Outperform from Neutral at Baird » 05:38
07/07/20
07/07
05:38
07/07/20
05:38
TREX

Trex Company

$126.42 /

-0.74 (-0.58%)

Baird analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TREX Trex Company
$126.42 /

-0.74 (-0.58%)

TREX Trex Company
$126.42 /

-0.74 (-0.58%)

06/23/20 Deutsche Bank
Trex Company price target raised to $130 from $88 at Deutsche Bank
06/18/20 Benchmark
Trex Company price target raised to $136 from $116 at Benchmark
05/05/20 SunTrust
Trex Company price target raised to $99 from $90 at SunTrust
05/05/20 Deutsche Bank
Trex Company price target raised to $88 from $79 at Deutsche Bank
TREX Trex Company
$126.42 /

-0.74 (-0.58%)

TREX Trex Company
$126.42 /

-0.74 (-0.58%)

Downgrade
Wihlborgs Fastigheter downgraded to Hold from Buy at Pareto » 05:37
07/07/20
07/07
05:37
07/07/20
05:37
WIHLY

Wihlborgs Fastigheter

$0.00 /

+ (+0.00%)

Pareto analyst Markus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WIHLY Wihlborgs Fastigheter
$0.00 /

+ (+0.00%)

05:33 Today DNB Markets
Wihlborgs Fastigheter downgraded to Hold from Buy at DNB Markets
Upgrade
Honda upgraded to Outperform from Neutral at SMBC Nikko » 05:36
07/07/20
07/07
05:36
07/07/20
05:36
HMC

Honda

$26.13 /

+0.305 (+1.18%)

SMBC Nikko analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HMC Honda
$26.13 /

+0.305 (+1.18%)

HMC Honda
$26.13 /

+0.305 (+1.18%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
05/12/20 CLSA
Honda downgraded to Underperform from Outperform at CLSA
04/13/20 Goldman Sachs
Honda upgraded to Buy from Neutral at Goldman Sachs
03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
HMC Honda
$26.13 /

+0.305 (+1.18%)

HMC Honda
$26.13 /

+0.305 (+1.18%)

HMC Honda
$26.13 /

+0.305 (+1.18%)

Downgrade
Rightmove downgraded to Sell from Hold at Investec » 05:36
07/07/20
07/07
05:36
07/07/20
05:36
RTMVY

Rightmove

$0.00 /

+ (+0.00%)

Investec analyst Alastair…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTMVY Rightmove
$0.00 /

+ (+0.00%)

06/26/20 Morgan Stanley
Rightmove price target lowered to 490 GBp from 500 GBp at Morgan Stanley
06/25/20 Berenberg
Rightmove downgraded to Sell from Hold at Berenberg
06/24/20 JPMorgan
Rightmove price target lowered to 428 GBp from 435 GBp at JPMorgan
06/23/20 Peel Hunt
Rightmove downgraded to Hold from Add at Peel Hunt
Upgrade
Schindler upgraded to Buy from Hold at Berenberg » 05:35
07/07/20
07/07
05:35
07/07/20
05:35
SHLAF

Schindler

$0.00 /

+ (+0.00%)

Berenberg analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHLAF Schindler
$0.00 /

+ (+0.00%)

06/24/20 HSBC
Schindler downgraded to Hold from Buy at HSBC
04/01/20 Morgan Stanley
Schindler price target lowered to CHF 185 from CHF 195 at Morgan Stanley
03/30/20 Exane BNP Paribas
Schindler downgraded to Underperform from Neutral at Exane BNP Paribas
03/05/20 Barclays
Schindler price target lowered to CHF 200 from CHF 205 at Barclays
Downgrade
Wihlborgs Fastigheter downgraded to Hold from Buy at DNB Markets » 05:33
07/07/20
07/07
05:33
07/07/20
05:33
WIHLY

Wihlborgs Fastigheter

$0.00 /

+ (+0.00%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Hugo Boss downgraded to Neutral from Outperform at Exane BNP Paribas » 05:30
07/07/20
07/07
05:30
07/07/20
05:30
BOSSY

Hugo Boss

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOSSY Hugo Boss
$0.00 /

+ (+0.00%)

06/29/20 Morgan Stanley
Hugo Boss price target lowered to EUR 28 from EUR 29 at Morgan Stanley
06/29/20 BofA
Hugo Boss downgraded to Underperform from Neutral at BofA
06/24/20 Morgan Stanley
Hugo Boss price target lowered to EUR 29 from EUR 46 at Morgan Stanley
05/29/20 Jefferies
Hugo Boss downgraded to Hold from Buy at Jefferies
Hot Stocks
Carnival announces ship delivery changes, cancellations of departures » 05:30
07/07/20
07/07
05:30
07/07/20
05:30
CCL

Carnival

$15.61 /

-0.275 (-1.73%)

Carnival Cruise Line will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$15.61 /

-0.275 (-1.73%)

CCL Carnival
$15.61 /

-0.275 (-1.73%)

06/23/20 Deutsche Bank
Carnival price target raised to $13 from $11 at Deutsche Bank
06/22/20 Redburn
Cruise Lines cut to Neutral at Redburn on signs of weaker demand recovery
06/22/20 Redburn
Carnival downgraded to Neutral from Buy at Redburn
06/19/20 Barclays
Carnival price target lowered to $18 from $53 at Barclays
CCL Carnival
$15.61 /

-0.275 (-1.73%)

  • 02
    Apr
CCL Carnival
$15.61 /

-0.275 (-1.73%)

CCL Carnival
$15.61 /

-0.275 (-1.73%)

CCL Carnival
$15.61 /

-0.275 (-1.73%)

General news
FX Action: USD-JPY has lifted back above 107.50 » 05:30
07/07/20
07/07
05:30
07/07/20
05:30

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
NGM Biopharmaceuticals initiated with a Buy at Chardan » 05:29
07/07/20
07/07
05:29
07/07/20
05:29
NGM

NGM Biopharmaceuticals

$19.04 /

-0.15 (-0.78%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGM NGM Biopharmaceuticals
$19.04 /

-0.15 (-0.78%)

NGM NGM Biopharmaceuticals
$19.04 /

-0.15 (-0.78%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
NGM NGM Biopharmaceuticals
$19.04 /

-0.15 (-0.78%)

NGM NGM Biopharmaceuticals
$19.04 /

-0.15 (-0.78%)

NGM NGM Biopharmaceuticals
$19.04 /

-0.15 (-0.78%)

Initiation
89bio initiated with a Buy at Chardan » 05:28
07/07/20
07/07
05:28
07/07/20
05:28
ETNB

89bio

$26.40 /

-1.03 (-3.76%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETNB 89bio
$26.40 /

-1.03 (-3.76%)

ETNB 89bio
$26.40 /

-1.03 (-3.76%)

12/09/19 Oppenheimer
89bio initiated with an Outperform at Oppenheimer
12/09/19 SVB Leerink
89bio initiated with an Outperform at SVB Leerink
12/09/19 RBC Capital
89bio initiated with an Outperform at RBC Capital
12/09/19 BofA/Merrill
89bio initiated with a Neutral at BofA/Merrill
ETNB 89bio
$26.40 /

-1.03 (-3.76%)

  • 08
    Jul
  • 11
    Nov
Initiation
Akero Therapeutics initiated with a Buy at Chardan » 05:28
07/07/20
07/07
05:28
07/07/20
05:28
AKRO

Akero Therapeutics

$35.09 /

+1.96 (+5.92%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$35.09 /

+1.96 (+5.92%)

AKRO Akero Therapeutics
$35.09 /

+1.96 (+5.92%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AKRO Akero Therapeutics
$35.09 /

+1.96 (+5.92%)

  • 08
    Jul
AKRO Akero Therapeutics
$35.09 /

+1.96 (+5.92%)

AKRO Akero Therapeutics
$35.09 /

+1.96 (+5.92%)

Hot Stocks
Endo announces FDA approval of Qwo » 05:26
07/07/20
07/07
05:26
07/07/20
05:26
ENDP

Endo

$3.62 /

+0.12 (+3.43%)

Endo International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$3.62 /

+0.12 (+3.43%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Jaffray
Endo upgraded to Overweight from Neutral at Piper Jaffray
ENDP Endo
$3.62 /

+0.12 (+3.43%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

Downgrade
Dominion downgraded to Underperform from Neutral at Mizuho » 05:26
07/07/20
07/07
05:26
07/07/20
05:26
D

Dominion

$73.60 /

-9.085 (-10.99%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
D Dominion
$73.60 /

-9.085 (-10.99%)

D Dominion
$73.60 /

-9.085 (-10.99%)

04:50 Today Credit Suisse
Dominion downgraded to Neutral from Outperform at Credit Suisse
07/06/20 Wells Fargo
Wells says merits of Dominion's 'forward-looking' deal to be clearer with time
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
07/06/20 JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
D Dominion
$73.60 /

-9.085 (-10.99%)

D Dominion
$73.60 /

-9.085 (-10.99%)

D Dominion
$73.60 /

-9.085 (-10.99%)

D Dominion
$73.60 /

-9.085 (-10.99%)

Hot Stocks
Sunrun announces agreement to acquire Vivint Solar in all-stock deal » 05:24
07/07/20
07/07
05:24
07/07/20
05:24
RUN

Sunrun

$21.35 /

+1.35 (+6.75%)

, VSLR

Vivint Solar

$10.63 /

+0.555 (+5.51%)

Sunrun (RUN) and Vivint…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
Sunrun price target raised to $22 from $20 at JPMorgan
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
03/25/20 Roth Capital
ITC extension 'NOT' in Phase 3 coronavirus rescue package, says Roth Capital
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

Upgrade
Hikma upgraded to Overweight from Equal Weight at Morgan Stanley » 05:24
07/07/20
07/07
05:24
07/07/20
05:24
HKMPF

Hikma Pharmaceuticals

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

05/22/20 Roth Capital
Roth Capital says buy Amarin as at-risk generic launch unlikely
05/22/20 Cantor Fitzgerald
COVID-19 trial validation of Vascepa's science, says Cantor Fitzgerald
04/28/20 Barclays
Hikma price target raised to 2,200 GBp from 1,950 GBp at Barclays
04/23/20 Goldman Sachs
Hikma Pharmaceuticals downgraded to Neutral from Buy at Goldman Sachs
HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

Downgrade
Unilever downgraded to Neutral from Buy at Bryan Garnier » 05:21
07/07/20
07/07
05:21
07/07/20
05:21
UN

Unilever

$53.75 /

-0.38 (-0.70%)

, UL

Unilever

$55.05 /

-0.665 (-1.19%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UN Unilever
$53.75 /

-0.38 (-0.70%)

UL Unilever
$55.05 /

-0.665 (-1.19%)

UN Unilever
$53.75 /

-0.38 (-0.70%)

07/06/20 RBC Capital
Unilever price target raised to EUR 34 from EUR 33 at RBC Capital
06/29/20 Barclays
Unilever price target raised to EUR 43.70 from EUR 43.10 at Barclays
06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 UBS
Unilever downgraded to Sell from Neutral at UBS
UL Unilever
$55.05 /

-0.665 (-1.19%)

07/06/20 RBC Capital
Unilever price target raised to EUR 34 from EUR 33 at RBC Capital
06/29/20 Barclays
Unilever price target raised to EUR 43.70 from EUR 43.10 at Barclays
06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 UBS
Unilever downgraded to Sell from Neutral at UBS
UN Unilever
$53.75 /

-0.38 (-0.70%)

UL Unilever
$55.05 /

-0.665 (-1.19%)

UN Unilever
$53.75 /

-0.38 (-0.70%)

UL Unilever
$55.05 /

-0.665 (-1.19%)

Hot Stocks
Sunrun announces agreement to acquire Vivint Solar for enterprise value of $3.2B  05:20
07/07/20
07/07
05:20
07/07/20
05:20
RUN

Sunrun

$21.35 /

+1.35 (+6.75%)

, VSLR

Vivint Solar

$10.63 /

+0.555 (+5.51%)

 
ShowHide Related Items >><<
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
Sunrun price target raised to $22 from $20 at JPMorgan
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
03/25/20 Roth Capital
ITC extension 'NOT' in Phase 3 coronavirus rescue package, says Roth Capital
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

Upgrade
Danone upgraded to Buy from Neutral at Bryan Garnier » 05:20
07/07/20
07/07
05:20
07/07/20
05:20
DANOY

Danone

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DANOY Danone
$0.00 /

+ (+0.00%)

DANOY Danone
$0.00 /

+ (+0.00%)

06/30/20 Exane BNP Paribas
Danone downgraded to Neutral from Outperform at Exane BNP Paribas
06/29/20 BofA
Danone downgraded to Neutral from Buy at BofA
06/29/20 UBS
Danone downgraded to Sell from Buy at UBS
06/04/20 Societe Generale
Danone price target raised to EUR 58 from EUR 52 at Societe Generale
DANOY Danone
$0.00 /

+ (+0.00%)

Upgrade
Nestle upgraded to Buy from Neutral at Bryan Garnier » 05:19
07/07/20
07/07
05:19
07/07/20
05:19
NSRGY

Nestle

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSRGY Nestle
$0.00 /

+ (+0.00%)

NSRGY Nestle
$0.00 /

+ (+0.00%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/04/20 Societe Generale
Nestle price target lowered to CHF 112 from CHF 113 at Societe Generale
05/05/20 JPMorgan
Nestle price target raised to CHF 116 from CHF 99 at JPMorgan
04/29/20 UBS
Nestle price target raised to CHF 114 from CHF 105 at UBS
NSRGY Nestle
$0.00 /

+ (+0.00%)

NSRGY Nestle
$0.00 /

+ (+0.00%)

Downgrade
Yeti downgraded to Neutral from Buy at Goldman Sachs » 05:11
07/07/20
07/07
05:11
07/07/20
05:11
YETI

Yeti

$43.09 /

+0.465 (+1.09%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$43.09 /

+0.465 (+1.09%)

YETI Yeti
$43.09 /

+0.465 (+1.09%)

06/23/20 Piper Sandler
Yeti price target raised to $47 from $35 at Piper Sandler
06/10/20 Cowen
Yeti price target raised to $41 from $31 at Cowen
06/09/20 BTIG
Yeti price target raised to $44 from $36 at BTIG
05/05/20 Piper Sandler
Yeti price target lowered to $34 from $50 at Piper Sandler
YETI Yeti
$43.09 /

+0.465 (+1.09%)

  • 28
    May
  • 11
    May
  • 17
    Feb
  • 07
    Nov
YETI Yeti
$43.09 /

+0.465 (+1.09%)

YETI Yeti
$43.09 /

+0.465 (+1.09%)

Recommendations
Activision Blizzard price target raised to $86 from $79 at Piper Sandler » 05:09
07/07/20
07/07
05:09
07/07/20
05:09
ATVI

Activision Blizzard

$78.67 /

+1.24 (+1.60%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

07/02/20 Needham
Activision Blizzard price target raised to $90 from $75 at Needham
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/29/20 Benchmark
Activision Blizzard price target raised to $85 from $77 at Benchmark
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

ATVI Activision Blizzard
$78.67 /

+1.24 (+1.60%)

Recommendations
Chiasma price target lowered to $19 from $22 at Piper Sandler » 05:07
07/07/20
07/07
05:07
07/07/20
05:07
CHMA

Chiasma

$4.72 /

+0.2 (+4.42%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHMA Chiasma
$4.72 /

+0.2 (+4.42%)

CHMA Chiasma
$4.72 /

+0.2 (+4.42%)

06/29/20 H.C. Wainwright
Chiasma price target raised to $11 from $10 at H.C. Wainwright
06/26/20 Piper Sandler
Chiasma price target raised to $22 from $13 at Piper Sandler
06/26/20 Cantor Fitzgerald
Chiasma approval a 'significant positive,' says Cantor Fitzgerald
06/26/20 Cantor Fitzgerald
Chiasma weakness 'unwarranted,' approval a 'giant leap,' says Cantor Fitzgerald
CHMA Chiasma
$4.72 /

+0.2 (+4.42%)

  • 01
    Jul
  • 26
    Jul
Recommendations
Acceleron price target lowered to $130 from $135 at Piper Sandler » 05:05
07/07/20
07/07
05:05
07/07/20
05:05
XLRN

Acceleron

$101.73 /

+0.36 (+0.36%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$101.73 /

+0.36 (+0.36%)

XLRN Acceleron
$101.73 /

+0.36 (+0.36%)

06/26/20 SVB Leerink
Acceleron price target raised to $132 from $127 at SVB Leerink
06/25/20 Morgan Stanley
Acceleron's 'impressive' data confirm sotatercept potential, says Morgan Stanley
06/25/20 Cowen
Acceleron price target raised to $140 from $121 at Cowen
06/25/20 RBC Capital
Acceleron price target raised to $99 from $72 at RBC Capital
XLRN Acceleron
$101.73 /

+0.36 (+0.36%)

  • 01
    Jul
XLRN Acceleron
$101.73 /

+0.36 (+0.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.